Zyprexa Removal From Florida Medicaid Drug List Recommended By P&T Cmte
Executive Summary
Use of Lilly's antipsychoticZyprexa would require prior authorization under Florida's Medicaid program should the state approve recommendations by a pharmacy & therapeutics committee
You may also be interested in...
Lilly’s Zyprexa, Cymbalta Will Be Dropped From Florida Medicaid Drug List
Florida Medicaid will reconsider the status of GlaxoSmithKline's Paxil, Forest's Lexapro and Pfizer's Zoloft on the state's preferred drug list in September after awarding the antidepressants conditional placement on the PDL
Lilly’s Zyprexa, Cymbalta Will Be Dropped From Florida Medicaid Drug List
Florida Medicaid will reconsider the status of GlaxoSmithKline's Paxil, Forest's Lexapro and Pfizer's Zoloft on the state's preferred drug list in September after awarding the antidepressants conditional placement on the PDL
Neurontin Off-Label Use Needs Prior Authorization Under Fla. Medicaid Plan
Prior authorization for off-label use of Pfizer's Neurontin would save the Florida Medicaid program $7 mil., the FY 2004-2005 budget proposal states